Differences between these groups were observed for history of venous thromboembolism, family history of cancer, and selected laboratory parameters including higher levels of D-dimers, ESR, CRP, pathologically low or high levels of platelets and lower levels of hemoglobin associated with cancer (Table 2; Fig. 4). This evidence concerns the gene ESR1 and venous thromboembolism.